Executive Summary

Breathe Right nasal strip maker will not launch new products in remainder of 2001, focusing instead on core brands including Fiberchoice chewable fiber product. Strong international growth, distribution helps firm achieve 85% top-line sales growth to $27.1 mil. in first quarter, CNS tells analysts April 19. International sales soared to $4.8 mil. from $296,000 in prior-year period. Breathe Right revenues rose 39% in quarter, primarily due to new strips with Vicks "mentholated vapors" and children's strips with graphics, COO/President Marti Morfitt notes. Direct response ad broke week of April 16 focusing on Breathe Right for allergies, an indication CNS plans to highlight into 2002, Morfitt says